Cargando…

Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer

ABSTRACT The conjunction of atrial fibrillation (AF) and venous thromboembolism (VTE) is common in clinical practice. Over the last 2 decades, a significant number of articles (2500) have been published about AF and VTE. To effectively analyze and present these vast amounts of information, this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Lina, Shi, Junhe, Yu, Haixu, Song, Lei, Zhu, Chunlin, Shi, Dazhuo, Gao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547310/
https://www.ncbi.nlm.nih.gov/pubmed/37586071
http://dx.doi.org/10.1161/JAHA.123.029810
_version_ 1785115034176716800
author Miao, Lina
Shi, Junhe
Yu, Haixu
Song, Lei
Zhu, Chunlin
Shi, Dazhuo
Gao, Jie
author_facet Miao, Lina
Shi, Junhe
Yu, Haixu
Song, Lei
Zhu, Chunlin
Shi, Dazhuo
Gao, Jie
author_sort Miao, Lina
collection PubMed
description ABSTRACT The conjunction of atrial fibrillation (AF) and venous thromboembolism (VTE) is common in clinical practice. Over the last 2 decades, a significant number of articles (2500) have been published about AF and VTE. To effectively analyze and present these vast amounts of information, this study uses bibliometric research methods to categorize and consolidate these publications. The number of publications has increased yearly, especially since 2012. The United States was the most prolific country, with 1054 studies published. The most productive institution was McMaster University. Gregory Y.H. Lip was the most prolific author. The keyword analysis identified that the research focuses from 2003 to 2014 were factor Xa inhibitor, dabigatran etexilate, direct thrombin inhibitor, double‐blind, deep vein thrombosis, molecular weight heparin, stroke prevention, etc. From 2015 to 2016, research mainly focused on venous thromboembolism, antithrombotic therapy, anticoagulant, warfarin, atrial fibrillation, stroke, and pulmonary embolism. Studies during 2017 to 2022 focused on apixaban, direct oral anticoagulant, rivaroxaban, dabigatran, hemorrhage, edoxaban, medicine efficacy and safety, risk factors, clinical management, and vitamin K antagonists. Since 2018, novel oral anticoagulants have been the most commonly used keywords. On the whole, most studies of AF and VTE focus on pathogenesis and therapeutic drugs. The causal relationship between AF and VTE, the effectiveness and safety of novel oral anticoagulants in the treatments, the anticoagulant regimen of AF and VTE co‐disease, and the treatment regimen for vulnerable populations such as the elderly or obese people were the focus of current research and will continue to be the central point of future research.
format Online
Article
Text
id pubmed-10547310
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105473102023-10-04 Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer Miao, Lina Shi, Junhe Yu, Haixu Song, Lei Zhu, Chunlin Shi, Dazhuo Gao, Jie J Am Heart Assoc Contemporary Review ABSTRACT The conjunction of atrial fibrillation (AF) and venous thromboembolism (VTE) is common in clinical practice. Over the last 2 decades, a significant number of articles (2500) have been published about AF and VTE. To effectively analyze and present these vast amounts of information, this study uses bibliometric research methods to categorize and consolidate these publications. The number of publications has increased yearly, especially since 2012. The United States was the most prolific country, with 1054 studies published. The most productive institution was McMaster University. Gregory Y.H. Lip was the most prolific author. The keyword analysis identified that the research focuses from 2003 to 2014 were factor Xa inhibitor, dabigatran etexilate, direct thrombin inhibitor, double‐blind, deep vein thrombosis, molecular weight heparin, stroke prevention, etc. From 2015 to 2016, research mainly focused on venous thromboembolism, antithrombotic therapy, anticoagulant, warfarin, atrial fibrillation, stroke, and pulmonary embolism. Studies during 2017 to 2022 focused on apixaban, direct oral anticoagulant, rivaroxaban, dabigatran, hemorrhage, edoxaban, medicine efficacy and safety, risk factors, clinical management, and vitamin K antagonists. Since 2018, novel oral anticoagulants have been the most commonly used keywords. On the whole, most studies of AF and VTE focus on pathogenesis and therapeutic drugs. The causal relationship between AF and VTE, the effectiveness and safety of novel oral anticoagulants in the treatments, the anticoagulant regimen of AF and VTE co‐disease, and the treatment regimen for vulnerable populations such as the elderly or obese people were the focus of current research and will continue to be the central point of future research. John Wiley and Sons Inc. 2023-08-10 /pmc/articles/PMC10547310/ /pubmed/37586071 http://dx.doi.org/10.1161/JAHA.123.029810 Text en © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Contemporary Review
Miao, Lina
Shi, Junhe
Yu, Haixu
Song, Lei
Zhu, Chunlin
Shi, Dazhuo
Gao, Jie
Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_full Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_fullStr Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_full_unstemmed Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_short Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
title_sort studies on atrial fibrillation and venous thromboembolism in the past 20 years: a bibliometric analysis via citespace and vosviewer
topic Contemporary Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547310/
https://www.ncbi.nlm.nih.gov/pubmed/37586071
http://dx.doi.org/10.1161/JAHA.123.029810
work_keys_str_mv AT miaolina studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT shijunhe studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT yuhaixu studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT songlei studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT zhuchunlin studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT shidazhuo studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer
AT gaojie studiesonatrialfibrillationandvenousthromboembolisminthepast20yearsabibliometricanalysisviacitespaceandvosviewer